Does NIVOLUMAB Cause Glomerulonephritis rapidly progressive? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Glomerulonephritis rapidly progressive have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.0% of all adverse event reports for NIVOLUMAB.
27
Reports of Glomerulonephritis rapidly progressive with NIVOLUMAB
0.0%
of all NIVOLUMAB reports
3
Deaths
17
Hospitalizations
How Dangerous Is Glomerulonephritis rapidly progressive From NIVOLUMAB?
Of the 27 reports, 3 (11.1%) resulted in death, 17 (63.0%) required hospitalization, and 1 (3.7%) were considered life-threatening.
Is Glomerulonephritis rapidly progressive Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Glomerulonephritis rapidly progressive?
HYDRALAZINE (292)
PREDNISONE (47)
TACROLIMUS (47)
METHOTREXATE (43)
MYCOPHENOLATE MOFETIL (43)
RITUXIMAB (40)
ADALIMUMAB (36)
PEMBROLIZUMAB (33)
CYCLOPHOSPHAMIDE (31)
ETANERCEPT (24)
Which NIVOLUMAB Alternatives Have Lower Glomerulonephritis rapidly progressive Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE